RTSX Insider Trading Activity and SEC Form 4 Filings
RTSX insider trading summary
No open-market insider purchases or sales of Radiation Therapy Services Inc (RTSX) have been reported on SEC Form 4 in the past 12 months.
Latest RTSX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 21, 2008 | James H Rubenstein | Medical Director | Sell | $36.6M (1,125,595 @ $32.50) |
| Feb 21, 2008 | Daniel E Dosoretz | Chief Executive Officer | Sell | $28.4M (875,195 @ $32.50) |
| Feb 21, 2008 | James H Rubenstein | Medical Director | Sell | $23.2M (714,535 @ $32.50) |
| Feb 21, 2008 | Howard M Sheridan | Chairman of the Board | Sell | $35.9M (1,105,580 @ $32.50) |
| Feb 21, 2008 | Michael J Katin | Director | Sell | $16.0M (492,308 @ $32.50) |
| Feb 21, 2008 | David N T Watson | Executive VP and CFO | Sell | $478K (14,711 @ $32.50) |
| Feb 21, 2008 | Ronald E Inge | Director | Sell | $163K (5,000 @ $32.50) |
| Feb 21, 2008 | Leo Doerr | Director | Sell | $81K (2,500 @ $32.50) |
| Feb 21, 2008 | Solomon Agin | Director | Sell | $4K (120 @ $32.50) |
| Feb 21, 2008 | Herbert F Dorsett | Director | Sell | $7K (200 @ $32.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.